{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:18:18Z","timestamp":1761844698543,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jiac.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T22:45:13Z","timestamp":1482273913000},"page":"319-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intracranial hypertension secondary to high dose cytosine arabinoside \u2013 A case study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-8096","authenticated-orcid":false,"given":"Z.A.","family":"Nurgat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2016.11.005_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2012-07-444851","article-title":"Sense and nonsense of high-dose Cytarabine for acute myeloid leukemia","volume":"121","author":"L\u00f6wenberg","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.11.005_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1010222","article-title":"Acute myeloid leukemia","volume":"364","author":"L\u00f6wenberg","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.11.005_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.1993.11.1.116","article-title":"Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy","volume":"11","author":"Gandhi","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jiac.2016.11.005_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/10428199309148532","article-title":"Fludarabine and arabinosyl cytosine therapy of refractory and relapsed acute myelogenous leukemia","volume":"9","author":"Estey","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jiac.2016.11.005_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.1991.9.4.679","article-title":"Cytarabine and neurologic toxicity","volume":"9","author":"Baker","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jiac.2016.11.005_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1345\/aph.18059","article-title":"Pseudotumorcerebri secondary to intermediate-dose Cytarabine HCl","volume":"33","author":"Fort","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2016.11.005_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.1992.tb04575.x","article-title":"Pseudotumourcerebri following high-dose cytosine arabinoside","volume":"80","author":"Evers","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2016.11.005_bib8","first-page":"162","article-title":"Intracranial hypertension following intrathecal administration of liposomal cytarabine","volume":"258","author":"Lunskens","year":"2011","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jiac.2016.11.005_bib9","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2003-07-2195","article-title":"The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients","volume":"103","author":"Ossenkoppele","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.11.005_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ccr3.308","article-title":"Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report","volume":"3","author":"Annaloro","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jiac.2016.11.005_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.jiac.2016.11.005_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MPH.0b013e318030ac3b","article-title":"Pseudotumorcerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis","volume":"29","author":"Somech","year":"2007","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jiac.2016.11.005_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"The idiopathic intracranial hypertension treatment trial. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss","volume":"311","author":"The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee","year":"2014","journal-title":"JAMA"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16302483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16302483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:12Z","timestamp":1761159372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X16302483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1341321X16302483"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2016.11.005","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracranial hypertension secondary to high dose cytosine arabinoside \u2013 A case study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}